Table 1.
Demographic characteristics of FTD patients and controls.
| Controls (N = 30) | All FTD patients (N = 16) | p-valuea | Probable tauopathy subgroup (N = 9) | p-valueb | ||
|---|---|---|---|---|---|---|
| Months of follow-up | ||||||
| Mean (SD) | 14.5 (3.2) | 15.6 (4.4) | 0.31 | 15.2 (4.2) | 0.56 | |
| Minimum, Maximum | 12, 25 | 11, 24 | 11, 24 | |||
| Age at baseline (years) | ||||||
| Mean (SD) | 53.1 (11.3) | 65.6 (8.2) | <0.001 | 65.8 (6.7) | <0.001 | |
| Minimum, Maximum | 26, 77 | 53, 87 | 53, 76 | |||
| Sex, n (%) | ||||||
| Male | 9 (30.0) | 6 (37.5) | 0.53 | 2 (22.2) | 1.00 | |
| Female | 21 (70.0 | 10 (62.5) | 7 (77.8) | |||
| Race, n (%) | ||||||
| Caucasian | 16 (53.3) | 13 (81.3) | <0.001 | 7 (77.8) | 0.01 | |
| African–American | 12 (40.0) | 0 (0.0) | 0 (0.0) | |||
| Other/unknown | 2 (6.7) | 3 (18.8) | 2 (22.2) |
FTD, frontotemporal degeneration; SD, standard deviation. ap-value for comparison of controls and patients. bp-value for comparison of controls and probable tauopathy subgroup.